Maine BioTek, Inc.

Company Information

Company Name
Maine BioTek, Inc.
Address
259 MAIN STREET
Suite 208
WINTERPORT, ME, 04496 0408
Phone
1 207-223-4662
URL
n/a
DUNS
121149640
Number of Employees
3

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$439,305.00
5
SBIR Phase II
$1,091,393.00
3
Chart code to be here

Award List

  1. Recombinant ISA Virus Vaccine

    Amount: $296,000.00

    Infectious salmon anemia (ISA) virus is an emerging pathogen of farmed Atlantic salmon (Salmo salar). The virus is among the fish pathogens listed in the Aquatic Animal Health Code of the Office Inter ...

    SBIR Phase II 2004 Department of Agriculture
  2. Preparation of an IHN Virus Whole Killed Vaccine: Retention of Neutralizing Epitope Integrity of the IHN Virus Glycoprotein During Viral...

    Amount: $75,000.00

    NON-TECHNICAL SUMMARY: IHN disease in farmed salmon and trout exerts a negative impact on the productivity and profitability of the aquaculture industry. The purpose of this project is to produce an e ...

    SBIR Phase I 2003 Department of Agriculture
  3. Recombinant ISA Virus Vaccine

    Amount: $75,000.00

    NON-TECHNICAL SUMMARY: ISA virus, an unclassified Orthomyxoviridae is an emerging pathogen associated with disease in farmed Atlantic salmon. Losses incurred in Maine due to ISA alone in 2002 are esti ...

    SBIR Phase I 2003 Department of Agriculture
  4. Potency, Efficacy and Standardization of a Whole Killed IHN Virus Vaccine

    Amount: $296,000.00

    The salmon and to a lesser extent the trout aquaculture industries in North America consider infectious hematopoietic necrosis virus a major threat to the current and future economic viability and sus ...

    SBIR Phase II 2005 Department of Agriculture
  5. A Multivalent Bacterial Vaccine for Atlantic Cod

    Amount: $95,000.00

    The goal of this project (Phase I ¿ III) is to develop a vaccine for the control of diseases in Atlantic cod caused by L. anguillarum and A. salmonicida. To accomplish this we have established the f ...

    SBIR Phase I 2006 Department of Commerce
  6. SBIR Phase I: Recombinant Infectious Hematopoietic Necrosis (IHN) Virus G Protein Vaccine

    Amount: $94,376.00

    This Small Business Innovation Research Phase I project is to develop a vaccine for the control of infectious hematopoietic necrosis (IHN) disease of salmon and trout. An efficacious, safe and reason ...

    SBIR Phase I 2003 National Science Foundation
  7. SBIR Phase I: Atlantic Cod Nodavirus Vaccine

    Amount: $99,929.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a novel recombinant vaccine for the control of viral nervous necrosis (VNN) of cultured Atlantic cod (Gadus morhua) in New ...

    SBIR Phase I 2006 National Science Foundation
  8. SBIR Phase II: Atlantic Cod Nodavirus Vaccine

    Amount: $499,393.00

    This Small Business Innovation Research (SBIR) Phase II project of develops a recombinant vaccine for the prevention of nodavirus disease of cultured Atlantic cod, fisheries of growing importanct to N ...

    SBIR Phase II 2007 National Science Foundation

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government